Are null segregants new combinations of heritable material and should they be regulated?

IF 4.9 Q1 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Frontiers in genome editing Pub Date : 2022-01-01 DOI:10.3389/fgeed.2022.1064103
Jack A Heinemann, Katrin Clark, Tessa C Hiscox, Andrew W McCabe, Sarah Z Agapito-Tenfen
{"title":"Are null segregants new combinations of heritable material and should they be regulated?","authors":"Jack A Heinemann,&nbsp;Katrin Clark,&nbsp;Tessa C Hiscox,&nbsp;Andrew W McCabe,&nbsp;Sarah Z Agapito-Tenfen","doi":"10.3389/fgeed.2022.1064103","DOIUrl":null,"url":null,"abstract":"<p><p>Through genome editing and other techniques of gene technology, it is possible to create a class of organism called null segregants. These genetically modified organisms (GMOs) are products of gene technology but are argued to have no lingering vestige of the technology after the segregation of chromosomes or deletion of insertions. From that viewpoint regulations are redundant because any unique potential for the use of gene technology to cause harm has also been removed. We tackle this question of international interest by reviewing the early history of the purpose of gene technology regulation. The active ingredients of techniques used for guided mutagenesis, e.g., site-directed nucleases, such as CRISPR/Cas, are promoted for having a lower potential per reaction to create a hazard. However, others see this as a desirable industrial property of the reagents that will lead to genome editing being used more and nullifying the promised hazard mitigation. The contest between views revolves around whether regulations could alter the risks in the responsible use of gene technology. We conclude that gene technology, even when used to make null segregants, has characteristics that make regulation a reasonable option for mitigating potential harm. Those characteristics are that it allows people to create more harm faster, even if it creates benefits as well; the potential for harm increases with increased use of the technique, but safety does not; and regulations can control harm scaling.</p>","PeriodicalId":73086,"journal":{"name":"Frontiers in genome editing","volume":"4 ","pages":"1064103"},"PeriodicalIF":4.9000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871356/pdf/","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in genome editing","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3389/fgeed.2022.1064103","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 2

Abstract

Through genome editing and other techniques of gene technology, it is possible to create a class of organism called null segregants. These genetically modified organisms (GMOs) are products of gene technology but are argued to have no lingering vestige of the technology after the segregation of chromosomes or deletion of insertions. From that viewpoint regulations are redundant because any unique potential for the use of gene technology to cause harm has also been removed. We tackle this question of international interest by reviewing the early history of the purpose of gene technology regulation. The active ingredients of techniques used for guided mutagenesis, e.g., site-directed nucleases, such as CRISPR/Cas, are promoted for having a lower potential per reaction to create a hazard. However, others see this as a desirable industrial property of the reagents that will lead to genome editing being used more and nullifying the promised hazard mitigation. The contest between views revolves around whether regulations could alter the risks in the responsible use of gene technology. We conclude that gene technology, even when used to make null segregants, has characteristics that make regulation a reasonable option for mitigating potential harm. Those characteristics are that it allows people to create more harm faster, even if it creates benefits as well; the potential for harm increases with increased use of the technique, but safety does not; and regulations can control harm scaling.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
零种族是否是可遗传物质的新组合,它们是否应该受到管制?
通过基因组编辑和其他基因技术,有可能创造出一类被称为零分离的生物。这些转基因生物(GMOs)是基因技术的产物,但被认为在染色体分离或删除插入后没有残留的技术痕迹。从这个观点来看,条例是多余的,因为利用基因技术造成伤害的任何独特潜力也已被消除。我们通过回顾基因技术监管目的的早期历史来解决这个国际关注的问题。用于引导诱变的技术的有效成分,例如,位点导向核酸酶,如CRISPR/Cas,被推广为具有较低的每个反应产生危害的潜力。然而,其他人认为这是试剂的理想工业特性,将导致基因组编辑被更多地使用,并使承诺的危害缓解化为乌有。不同观点之间的争论围绕着监管是否能改变负责任地使用基因技术的风险展开。我们的结论是,基因技术,即使用于制造零分离,也具有使监管成为减轻潜在危害的合理选择的特点。这些特征是,它允许人们更快地制造更多的伤害,即使它也能带来好处;随着技术使用的增加,潜在的危害会增加,但安全性不会增加;法规可以控制损害规模。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
7.00
自引率
0.00%
发文量
0
审稿时长
13 weeks
期刊最新文献
Towards functional maps of non-coding variants in cancer. Beyond the traditional distinctions of genome editing: evaluating a vulnerability framework. Knockout mutation in TaD27 enhances number of productive tillers in hexaploid wheat. Targeting DLBCL by mutation-specific disruption of cancer-driving oncogenes. The potential of HBV cure: an overview of CRISPR-mediated HBV gene disruption.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1